Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Sep 30, 2019 at 10:15 AM EDT

Ovarian Cancer Study Suffers Big Setback

ImmunoGen shares dropped on Monday after the firm released data from its late-stage ovarian cancer study at the European Society…

Chris Lange | Sep 30, 2019 at 9:35 AM EDT

Are Dova Pharma Investors Getting the Most Out of This Acquisition?

Dova Pharmaceuticals shares jumped on Monday after the firm announced that it would be acquired by Swedish Orphan Biovitrum, or…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Chris Lange | Sep 27, 2019 at 9:55 AM EDT

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and…

John Harrington | Sep 27, 2019 at 8:31 AM EDT

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Between 2009 and 2017, the percentage of American children and teens aged 3 to 17 who were diagnosed with developmental…

Chris Lange | Sep 26, 2019 at 10:30 AM EDT

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Enanta Pharma shares dropped on Thursday after the company announced topline results from its Argon-1 Phase 2a study of EDP-305…

Paul Ausick | Sep 25, 2019 at 3:54 PM EDT

Has Amazon Bigfooted Teladoc?

Amazon has launched a telemedicine smartphone app for some Seattle-based employees. The news dented Teladoc's share price, but not as…

John Harrington | Sep 25, 2019 at 11:58 AM EDT

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Green tea has long been hailed for a variety of health benefits. Among other things, it is said to improve…

Chris Lange | Sep 25, 2019 at 11:40 AM EDT

Achillion Pharma Wins Big With FDA Breakthrough

Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan…

Chris Lange | Sep 25, 2019 at 10:10 AM EDT

Why This Cardiopulmonary Trial Is a Big Hit

PhaseBio Pharma shares jumped on Wednesday after the firm announced results from its midstage trial focused on novel therapies for…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 24, 2019 at 10:25 AM EDT

Why This Colorectal Cancer Treatment Approval Is a Big Hit

One analyst sees FDA approval of its noninvasive colorectal cancer screening test tacking on another 30% to Exact Sciences stock.

Chris Lange | Sep 23, 2019 at 3:29 PM EDT

Viela Bio Gears Up For IPO

Viela Bio filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its IPO. The company…

Chris Lange | Sep 23, 2019 at 12:10 PM EDT

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

Acadia shares made a handy gain on Monday after the firm announced positive results from an eight-week Phase 2 study…

1 … 83 84 85 86 87 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Ovarian Cancer Study Suffers Big Setback

Are Dova Pharma Investors Getting the Most Out of This Acquisition?

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Good News for Teens Suffering Atopic Dermatitis

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Has Amazon Bigfooted Teladoc?

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Achillion Pharma Wins Big With FDA Breakthrough

Why This Cardiopulmonary Trial Is a Big Hit

Major Biotechs Scare Off Short Sellers

Short Sellers Grow More Selective in Big Pharma

Why This Colorectal Cancer Treatment Approval Is a Big Hit

Viela Bio Gears Up For IPO

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

How Much Do You Need Invested by 50 to Retire on Dividends at 60?

He Worked for Three Electrical Contractors and Paid Too Much Social Security Tax. The Refund Was Hiding on His 1040.

‘There’s No Trick, No Smoke and Mirrors, No Man Behind the Curtain’: Dave Ramsey Dismantles Mortgage Payoff Scheme Targeting 64-Year-Old With $85,000 Left on His Home

How Much Do You Need Invested by 50 to Retire on Dividends at 60?

He Worked for Three Electrical Contractors and Paid Too Much Social Security Tax. The Refund Was Hiding on His 1040.

How Much Do You Need Invested by 50 to Retire on Dividends at 60?

He Worked for Three Electrical Contractors and Paid Too Much Social Security Tax. The Refund Was Hiding on His 1040.

Health and Healthcare Articles

All Health and Healthcare Articles

Ovarian Cancer Study Suffers Big Setback

Are Dova Pharma Investors Getting the Most Out of This Acquisition?

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Good News for Teens Suffering Atopic Dermatitis

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Has Amazon Bigfooted Teladoc?

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Achillion Pharma Wins Big With FDA Breakthrough

Why This Cardiopulmonary Trial Is a Big Hit

Major Biotechs Scare Off Short Sellers

Short Sellers Grow More Selective in Big Pharma

Why This Colorectal Cancer Treatment Approval Is a Big Hit

Viela Bio Gears Up For IPO

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

How Much Do You Need Invested by 50 to Retire on Dividends at 60?

He Worked for Three Electrical Contractors and Paid Too Much Social Security Tax. The Refund Was Hiding on His 1040.

‘There’s No Trick, No Smoke and Mirrors, No Man Behind the Curtain’: Dave Ramsey Dismantles Mortgage Payoff Scheme Targeting 64-Year-Old With $85,000 Left on His Home

Featured Reads

How Much Do You Need Invested by 50 to Retire on Dividends at 60?

He Worked for Three Electrical Contractors and Paid Too Much Social Security Tax. The Refund Was Hiding on His 1040.